| Dr James Praveen Anthony, MD | |
|
1101 Glendale Blvd, Suite 103, Valparaiso, IN 46383-3767 | |
| (219) 464-9054 | |
| (219) 465-1749 |
| Full Name | Dr James Praveen Anthony |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 26 Years |
| Location | 1101 Glendale Blvd, Valparaiso, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639356025 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Health - Porter | Valparaiso, IN | Hospital |
| La Porte Hospital | La porte, IN | Hospital |
| Indiana University Health Starke Hospital | Knox, IN | Hospital |
| Franciscan St Anthony Health - Michigan City | Michigan city, IN | Hospital |
| St Mary Medical Center Inc | Hobart, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Porter Physician Services Llc | 1850482407 | 91 |
News Archive
The U.S. Food and Drug Administration announced today that the manufacturer of Avandia (rosiglitazone), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed warning in the drug's labeling about potential increased risk for heart attacks.
New York University College of Dentistry has been selected as one of five institutions that are sharing a $20.7 million grant from the National Institute of Dental and Craniofacial Research (NIH) to the Forsyth Institute to find new ways to diagnose and fight periodontal disease.
An international team of scientists, including those at the Translational Genomic Research Institute (TGen), have discovered new avenues of potential treatments for a rare and deadly cancer known as Adrenocortical Carcinoma, or ACC.
The Calorie Control Council stated today that research findings presented during a poster session at the International Stroke Conference claiming an association between diet soft drink consumption and increased risk of stroke and heart attack are critically flawed.
› Verified 1 days ago
| Entity Name | Porter Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508075680 PECOS PAC ID: 1850482407 Enrollment ID: O20070810000409 |
News Archive
The U.S. Food and Drug Administration announced today that the manufacturer of Avandia (rosiglitazone), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed warning in the drug's labeling about potential increased risk for heart attacks.
New York University College of Dentistry has been selected as one of five institutions that are sharing a $20.7 million grant from the National Institute of Dental and Craniofacial Research (NIH) to the Forsyth Institute to find new ways to diagnose and fight periodontal disease.
An international team of scientists, including those at the Translational Genomic Research Institute (TGen), have discovered new avenues of potential treatments for a rare and deadly cancer known as Adrenocortical Carcinoma, or ACC.
The Calorie Control Council stated today that research findings presented during a poster session at the International Stroke Conference claiming an association between diet soft drink consumption and increased risk of stroke and heart attack are critically flawed.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Praveen Anthony, MD 1101 Glendale Blvd, Suite 103, Valparaiso, IN 46383-3767 Ph: (219) 464-9054 | Dr James Praveen Anthony, MD 1101 Glendale Blvd, Suite 103, Valparaiso, IN 46383-3767 Ph: (219) 464-9054 |
News Archive
The U.S. Food and Drug Administration announced today that the manufacturer of Avandia (rosiglitazone), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed warning in the drug's labeling about potential increased risk for heart attacks.
New York University College of Dentistry has been selected as one of five institutions that are sharing a $20.7 million grant from the National Institute of Dental and Craniofacial Research (NIH) to the Forsyth Institute to find new ways to diagnose and fight periodontal disease.
An international team of scientists, including those at the Translational Genomic Research Institute (TGen), have discovered new avenues of potential treatments for a rare and deadly cancer known as Adrenocortical Carcinoma, or ACC.
The Calorie Control Council stated today that research findings presented during a poster session at the International Stroke Conference claiming an association between diet soft drink consumption and increased risk of stroke and heart attack are critically flawed.
› Verified 1 days ago
Dr. Mazen Zaitoon, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 85 East United States 6 Frontage, Valparaiso, IN 46383 Phone: 219-983-8300 | |
Douglas Adolph Mazurek, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1101 Glendale Blvd, Suite 103, Valparaiso, IN 46383 Phone: 219-464-9054 Fax: 219-465-1749 | |
Michael Christopher Hansen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6, Valparaiso, IN 46383 Phone: 219-464-9054 Fax: 219-465-1749 | |
John Dougherty, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 56 Willow St, Valparaiso, IN 46383 Phone: 219-309-7254 | |
Dr. Akshay R. Trivedi, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2206 Roosevelt Rd Ste A, Valparaiso, IN 46383 Phone: 219-464-2285 | |
George E Sloan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 Roosevelt Rd, Valparaiso, IN 46383 Phone: 219-464-1620 Fax: 219-477-4565 | |
Dr. Jay Shah, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6 Ste 300, Valparaiso, IN 46383 Phone: 219-983-6300 Fax: 219-263-7620 |